[1]
“ASSESSING LONG-TERM SERUM SAMPLE VIABILITY FOR CARDIOVASCULAR RISK PREDICTION IN RHEUMATOID ARTHRITIS”, IJITCE, vol. 8, no. 2, pp. 60–74, May 2020, Accessed: Jan. 23, 2026. [Online]. Available: https://ijitce.org/index.php/ijitce/article/view/146